Denmark acted coordinator in EU Commission's work on decentralized clinical trials
New guidelines for decentralized clinical trials in the EU have been agreed to by participating parties, and the Danish representation claims to have had a special role.
by ulrich quistgaard, translated by daniel pedersen
The Danish Medicines Agency has acted as coordinator in the work behind new EU guidelines for decentralized clinical trials, the agency writes in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
